Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Dianthus Therapeutics, Inc.

DNTH Technical Analysis Summary (NASDAQ)

Analyze DNTH on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

DNTH●NASDAQ
HealthcareBiotechnology
$107.69
$1.49(1.40%)
U.S. Market opens in NaNh NaNm

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

DNTH Technical Analysis Summary (NASDAQ)

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.

Overall Sentiment:Neutral
Momentum:Neutral to Bullish (RSI: 50.26)
Trend Strength:Weak (ADX: 15.93)
Volatility:Medium (ATR: 5.05)
Support/Resistance:$102.71 – $115.57 (Bollinger Bands)

Technical conditions suggest Dianthus Therapeutics, Inc. on the NASDAQ is awaiting a decisive move. Technical conditions suggest Dianthus Therapeutics, Inc. is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 50.26

Bullish
Above midpoint suggests upward bias.

Stochastic %K: 33.66

Bearish
Momentum remains weak below midpoint.

Williams %R: -50.24

Neutral
Balanced market without strong signals.

Rate of Change (ROC): -2.15

Bearish
Selling pressure outweighs buying.

Takeaway:Dianthus Therapeutics, Inc. shows neutral momentum, with indicators pointing to indecision.

Trend & Volatility

MACD: -0.19

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 15.93

Weak
Weak trend, market trading sideways.

ATR (14): 5.05

High
High volatility, wide price fluctuations.

CCI (14): 0.55

Neutral
Neutral, no strong directional signal.

Takeaway:Dianthus Therapeutics, Inc. shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$115.57
Middle Band (SMA 20)
$109.14
Lower Band
$102.71
Current Position
Within Bands

Takeaway:Dianthus Therapeutics, Inc. trades closer to support, showing weaker momentum within bands.

Keltner Channels
Upper Channel
$117.94
Middle Line (EMA 20)
$107.84
Lower Channel
$97.73
Squeeze Status
Squeeze On

Takeaway:Dianthus Therapeutics, Inc. trades around the middle line, reflecting balanced price action.

Volume & Money Flow Analysis
On-Balance Volume17.81M
Money Flow Index64.77Bullish, inflows support continued momentum.
Relative Vigor Index55.92Neutral to Bullish, buyers hold a slight edge.

Overall Takeaway:DNTH shows bullish money flow, with volume and vigor supporting buyers.

Technical Trading Signals Summary
Based on the current technical analysis of Dianthus Therapeutics, Inc. (NASDAQ: DNTH), here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

Overall Recommendation:Technical indicators for Dianthus Therapeutics, Inc. are mixed, suggesting a Hold or wait-and-see approach.

(NASDAQ: DNTH) Technical Analysis FAQ